Multiplexed immunoassay for a serum autoantibody biomarker panel in diagnostic and prognostic prediction of canine mammary tumors

• Published in: The Veterinary quarterly Vol. 45; no. 1; pp. 1 - 12
• Main Authors: Wu, Chih-Ching, Chang, Chia-Yu, Chou, Pei-Yi, Chan, Xiu-Ya, Huang, Chun-Chueh, Yang, Youngsen, Liu, Hao-Ping
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 01.12.2025; Taylor & Francis Group
• Subjects: Animals; Autoantibodies - blood; autoantibody; biomarker; Biomarkers, Tumor - blood; Canine mammary tumor; Dog Diseases - blood; Dog Diseases - diagnosis; Dog Diseases - immunology; Dogs; Female; Immunoassay - methods; Immunoassay - veterinary; Mammary Neoplasms, Animal - blood; Mammary Neoplasms, Animal - diagnosis; Mammary Neoplasms, Animal - immunology; multiplexed assay; Prognosis; Sensitivity and Specificity; serum; autoantibody; multiplexed assay; biomarker; serum; Canine mammary tumor

Canine mammary tumor (CMT) is a prevalent and destructive disease often diagnosed at an advanced stage, leading to poor outcomes. Currently, there is a lack of effective biomarkers for early detection and prognostic prediction of CMT. To improve CMT detection, we established a multiplexed immunoassa...